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number of breath-holds required were observed during the 
courses of treatment. 
 
 
 
Conclusion: Breath-hold capabilities are highly individual and 
generally not observed to be changing during the course of 
treatment. The ratio between DIBH and FB total lung volume 
was observed to be stable during the course of treatment, 
while systematic decreases in GTV were observed both in 
DIBH and FB. DIBH radiotherapy of locally advanced NSCLC 
patients is considered to be feasible with geometrical 
reproducibility. 
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Purpose or Objective: The aim of radiotherapy is accurate 
delivery of dose to target volumes within a patient, while 
minimizing dose to the surrounding healthy tissue. 
Respiratory motion is still a significant problem in many 
radiotherapy treatments. Recent developments in the 
treatment of breast cancer have focused on “gating” the 
delivery of the treatment beams. With this technique, the 
effect of patient motion during treatment is reduced and the 
separation between the target volume and organs at risk 
(OAR) increased. Rapidly switching the treatment beam on or 
off, depending on the patient breathing cycle is the basic 
principle of gating. It is therefore important that the 
characteristics of gated treatments such as latency are 
known. 
 
Material and Methods: For this study, an in-house built 
electrical PIN diode circuit was designed to function as a tool 
for quality assurance (QA). Beam latency timing properties 
were measured on a TrueBeam™ (Varian, Palo Alto) linear 
accelerator and its internal gating system. Pulses of 
radiation, triggered within a predefined gating window, were 
measured with the PIN diode and the results compared to 
measurements of current through the linac target. A phantom 
consisting of the electrical circuit coupled to a moving stage 
was used to simulate a binary pattern to produce fast beam 
triggering. Processing of the beam pulses and calculation of 
the latency timings was performed by an Atmega328P 
microcontroller (MCU). All measurements were performed 
with photon energies 6MV and 10MV and a dose rate of 
600MU/min (equivalent to a reference dose in water of 6 
Gy/min). For every measurement, a total of 50 data points 
were collected and the results compared by calculating the 
arithmetic mean value and the standard deviation.  
 
 
Results: The results of the beam latency measurements are 
shown in the table below. 
 
Beam on 
latency (ms)  
Beam off 
latency (ms)  
Energy Target I PIN diode Target I PIN diode 
6 MV 2.13 ±1.15 2.11 ±1.05 57.33 ±10.01 57.69 ±9.59 
10 MV 2.15 ±1.06 2.12 ±1.09 56.01 ±10.10 57.73 ±10.06 
 
Conclusion: Measuring beam gating latencies of a linear 
accelerator via beam pulse analyses with the help of a PIN 
diode and the in-house built electrical circuit is a useful 
method in good agreement with measurements from the 
accelerator target current signal. The PIN diode circuit 
provided a good response when using different beam energies 
and can be a useful tool to perform QA on different types of 
linear accelerators and gating systems. This could potentially 
lead to improvements in the gated radiotherapy treatments. 
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Purpose or Objective: Respiration motion during 
radiotherapy of breast cancer patients will perturb the 
delivered dose. The accuracy of the delivered dose can be 
measured by in vivo EPID dosimetry. The respiration motion 
can be reduced by use of the Active Breathing Coordinator 
(ABC) produced by Elekta. This study investigates whether a 
difference in EPID measured acceptance pass rate is 
associated to the use of ABC and whether the residual 
breathing variation while using the ABC system is associated 
to the measured pass rate. 
 
Material and Methods: 15 ABC and 10 non-ABC breast cancer 
patients were monitored by EPID dosimetry for up to five 
fractions during the treatment. In total 185 and 82 tangential 
fields were available for analysis for ABC and non-ABC 
groups, respectively. The in vivo EPID dosimetry system 
(Wendling et al. Med Phys 2006) back projects the dose to a 
plane parallel to the EPID panel that includes the prescription 
point. The dose is compared to the planned distribution using 
a gamma analysis (3%, 3mm) and defines the pass rate as the 
fraction of gamma values less than one. Since pass rates are 
not normally distributed comparison between the ABC and 
non-ABC group was performed by a Mann-Whitney U test. The 
ABC system measured the amount of actual inhaled air at 
each treatment session and during the treatment planning 
CT. At breath-holds during treatment, deviation in inhaled air 
